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A previously detected copy number polymorphism (Ep CNP) in patients affected with neuroectodermal tumors led us to investigate its
frequency and length in the normal population. For this purpose, a program called Sequence Allocator was developed and applied for the
construction of an array that consisted of unique and duplicated fragments, allowing the assessment of copy number variation within regions of
segmental duplications. The average resolution of this array was 11 kb and we determined the size of the Ep CNP to be 290 kb. Analysis of normal
controls identified 7.7 and 7.1% gains in peripheral blood and lymphoblastoid cell line (LCL) DNA, respectively, while deletions were found only
in the LCL group (7.1%). This array platform allows the detection of DNA copy number variation within regions of pronounced genomic
complexity, which constitutes an improvement over available technologies.
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CGH) has evolved as a superior technique, due to its high
resolution, accuracy, and sensitivity of analysis [1–3]. This
method has proven to be particularly powerful for the mapping
of regions that may contain genes involved in tumor
development or progression. Numerous sets of tumors have
already been analyzed using various arrays composed of
genomic clones, cDNA, PCR fragments, or oligonucleotides,
with either genome-wide, chromosomal- or region-specific
coverage [3,4]. However, array-CGH analysis of genetic
variation in DNA derived from phenotypically normal
individuals is still in its early stages. Few studies in recent
years have highlighted the existence of a previously unchar-⁎ Corresponding author. Fax: +46 18 558931.
E-mail address: cecilia.bustos@genpat.uu.se (C. de Bustos).
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doi:10.1016/j.ygeno.2006.03.016acterized variation in the human genome [4–7]. We have
previously constructed a full-coverage clone-based chromo-
some 22 microarray and applied it to profile DNA copy
number alterations in several chromosome 22-related diseases
[8–11]. In the course of these studies, numerous loci that are
susceptible to DNA copy number variation in both tumor and
constitutional DNA were identified. One such copy number
polymorphism (CNP) was characterized in a study of 33 cases
affected with ependymoma [8], which is a tumor of the central
nervous system arising from the ependymal lining of the
cerebral ventricles as well as from the remnants of the central
spinal canal [12]. In this study, two overlapping interstitial
hemizygous deletions mapping to 22q11.23, ∼2.2 Mb and
∼300 kb in size, were found in two unrelated patients. These
alterations were present in both the tumor and the constitu-
tional DNA and were inherited from one of the respective
unaffected parents.
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within one of numerous regions from 22q containing
segmental duplications (SDs), which makes analysis of this
region considerably more difficult. SDs are structures with a
high degree of sequence similarity (>90%), involving the
movement of blocks (up to several hundred kb) of genomic
sequence to one or more locations in the genome [13,14]. SDs
can be either intra- or interchromosomal and are generally
assumed to arise through nonallelic homologous recombina-
tion (NAHR) [14–16]. SDs account for ∼5.3% of the total
human genome, while at least 10% of chromosome 22 is
composed of SDs. With the exception of DiGeorge syndrome,
in which the involvement of SD-mediated rearrangements is
well documented, the medical relevance of other 22q-located
SDs remains largely unresolved [17,18]. Many CNPs have
been suggested to arise due to the presence of SDs in the
intervening sequences, which mediate gene copy number
changes via NAHR [15,19]. Different approaches have been
taken to study specific regions of SDs by array-CGH, with
resolutions of down to ∼140 kb [20,21]. In our group, several
arrays based on strictly nonrepetitive and nonredundant
sequences have been constructed to profile series of neurofi-
bromatosis type 1 (NF1) and 2 (NF2) and schwannomatosis
patients. The arrays were built in segments of considerable
genomic complexity and had a resolution varying from 6.4 to
14.8 kb [22–25]. In this study we aimed to establish a
methodology assessment of gene copy number variation within
regions containing very limited amounts of nonredundant
sequences. We also applied it for the determination of the
length and frequency of Ep CNP in a normal control
population. For this purpose, we constructed a PCR product-
based array in which only unique (present in two copies in a
diploid genome) or duplicated (present in four copies) genomic
sequences were printed on the array as hybridization targets.
To facilitate the development of such array platform, we
developed a program, called Sequence Allocator, which works
through a web-based interface and controls three main
programs, namely: RepeatMasker (http://www.repeatmasker.
org), BLAST (http://www.ncbi.nlm.nih.gov/blast), and Primer3
(http://www.frodo.wi.mit.edu/primer3/). This software auto-
mates the design of PCR primers for the amplification of
unique (repeat-free and nonredundant) fragments that are
subsequently printed on the array. This program also allows
selection of duplicated sequences for gene dosage measure-
ments. We show here that the use of PCR fragments
representing unique or duplicated sequences as array data
points allows the accurate assessment of CNPs within complex
loci without decreasing the resolution of analysis.
Results
Development of the Sequence Allocator program for the design
of high-resolution arrays
To design repeat-free, nonredundant, PCR product-based
microarrays, a bioinformatic program, called Sequence Allo-
cator, was developed (demo is available at http://puffer.genpat.uu.se/DEMO/, after registration). This software package
(abbreviated as Allocator) fully automates the selection of
repeat-free and nonredundant regions in large segments of
chromosomes (typically a few million base pairs in one run)
and subsequently designs suitable PCR primers within these
sequences. Allocator works through a web-based interface and
controls three main programs, namely: RepeatMasker, BLAST,
and Primer3. Once the DNA sequence of interest is loaded into
Allocator, the program first masks common high-copy repeats
using a local copy of RepeatMasker and produces a list of
repeat-free regions longer than a specified minimum length of
PCR products. Subsequently, each repeat-free region is
automatically compared to the current working draft sequence
of the human genome located on the NCBI BLAST server,
using the standard nucleotide–nucleotide BLAST (blastn)
program. Allocator uses the results from BLAST to exclude
regions with multiple matches (“redundant regions”), according
to specified similarity thresholds (usually 80% identity over
>50 bp), and generates a list of nonredundant regions. Finally,
Allocator utilizes a local copy of the Primer3 program to design
PCR primers within these unique regions. A list of primers,
designed to amplify optimal nonoverlapping PCR fragments of
specified length (usually 100–1000 bp), is obtained as the final
output of the program.
Construction of a high-resolution microarray within the region
spanning Ep CNP
To characterize in detail the size and frequency of the
deletion/insertion polymorphism Ep CNP, we designed a
repeat-free, nonredundant PCR product-based microarray,
covering the deleted locus and adjacent segments of 22q11.2.
A 740-kb segment (chromosome 22 position 23,755,973–
24,495,449; build 35.1) was submitted to Allocator and a list
of PCR primers was obtained (see Table S2). Interestingly,
after Allocator analysis, a contiguous region of 390 kb
(chromosome 22 position 23,947,549–24,338,077) could be
identified for which only very few primers were designed, due
to the presence of a high content of either common repeats or
other redundant sequences, namely SDs. Contiguous segments
of redundant sequence identified by Allocator, with a
minimum size of 1 kb and showing at least 90% similarities
to other locations in the human genome, were regarded as
potential SDs. More detailed analysis revealed the presence of
a high sequence complexity, with multiple large SD modules.
This region of 22q (chromosome 22 position 23,755,973–
24,495,449), which is rich in SDs and includes Ep CNP, will
be abbreviated throughout the paper as “SD-22q.” A graphical
description of the SD modules identified by Allocator is shown
in Fig. 1. Within this SD-22q segment, modules I, III, and VI
were present twice, while module II was present three times.
Module IV was duplicated elsewhere on 22q (not shown),
while module V was duplicated on chromosome 11q13.4 (Fig.
1). Module V was the longest (∼60 kb) and it was the only
interchromosomal duplication.
Tomonitor the length of EpCNP accurately, a comprehensive
representation of the entire locus on the array was required.
Fig. 1. Detailed illustrations of segmental duplications (SDs) and PCR products included in the high-resolution array. (A) 740-kb sequence including the Ep CNP locus from 22q11.2, denoted as SD-22q. From top to
bottom: position on chromosome 22 in Mb, genomic clones from the minimal tiling path spanning across the locus, blocks of segmental duplications SDs, PCR products included in high-resolution array, pools of PCR
products constituting the array data points, genes located in this region, and the extent of the Ep CNP. Different modules within the SDs are labeled as follows: intrachromosomal duplications I (red), II (yellow), III (blue),
IV (green), and VI (gray) as well as interchromosomal duplication V (orange). Arrows indicate the orientation of the duplicated blocks. Modules I, II, III, and VI are duplicated within the studied locus toward the
telomere of 22q. Module IV is duplicated in many additional parts of chromosome 22 (not shown), whereas module V is duplicated on 11q13.4. Each vertical bar in the row depicting PCR fragments represents a single
PCR product and the width of each bar is proportional to the length of the PCR product. The majority of PCR products are nonrepetitive and nonredundant, thus allowing a precise determination of gene copy number.
However, within the SDs, there were no unique sequences available for primer design. We designed therefore redundant PCR fragments, although only for sequences present in four copies in the human genome.
Complete nonrepetitive and nonredundant PCR products are clustered together and the redundant PCR products (designed on duplicated sequences) are clustered separately, to facilitate gene copy number analysis. The
latter PCR pools are marked with an asterisk. Pools of PCR products (manually selected) are represented by brackets. Average total length of genomic sequences included in each PCR product pool is 2 kb. Genes are
















Fig. 2. Graphical output of the Sequence Allocator results for the Ep CNP locus. Positions on chromosome 22 are displayed on the x axis. Expected sizes of PCR
products are shown on the y axis. The horizontal bars at the top of the graph represent genomic clones spanning the locus. Filled squares symbolize nonrepetitive and
nonredundant PCR fragments. Open circles indicate nonrepetitive but redundant PCR products, representing sequences expected to occur four times in the human
genome.
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measurement points within regions of SD-22q, the array was
supplemented with PCR fragments representing duplicated
sequences present in four copies throughout the genome,
which substantially increases the resolution of analysis. Data
points present six or more times in the genome were not
included in the array because interpretation of results on gene
copy number changes for these data points is currently
unreliable.
Fig. 2 displays the graphical output of Allocator from the
analysis of SD-22q. As module V is duplicated on 11q13.4, we
constructed an array covering not only the 22q11 locus but also
11q13. With this approach, we could assess whether Ep CNP
was located on chromosome 22 or 11. The region of interest on
11q13 (chromosome 11 position 67,675,429–68,055,969,
abbreviated as SD-11q) was submitted to Allocator and primers
were designed using the same parameters as for chromosome
22. The SD-11q region spans the low-density lipoprotein
receptor protein 5 gene (LRP5) and some of the interchromo-
somal duplications from chromosome 22 module V are located
within this gene (Fig. 1B). Neighboring PCR products were
pooled so that each pool contained ∼2 kb of genomic sequence.
Independent pools of PCR fragments representing unique or
duplicated sequences were made by manual assessment (Fig. 1).
The section of the microarray covering SD-22q has an average
resolution of 11 kb and thus increases the resolution of analysis
seven times, compared to the 75-kb average resolution of the
genomic clone-based chromosome 22 microarray [10]. The
average resolution of the array section covering SD-11q is 9 kb
(Fig. 1). The array also contains PCR control pools from other
regions of chromosome 22, chromosome X, and non-chromo-
some 22-derived autosomal controls (see Table S2). In
summary, the array comprises 265 PCR pools (877 PCR
products), each pool composed of two to six PCR fragments
with a length of 100–1000 bp.Profiling of the copy number polymorphism in SD-22q and
SD-11q using the high-resolution microarray
This high-resolution array was applied to study 26 samples of
peripheral blood-derived DNA from normal individuals of
mixed ethnic origin (Caucasians, Asians, and South Americans).
Furthermore, we used this array to analyze 42 lymphoblastoid
cell line (LCL)-derived DNA samples from normal Caucasians.
A pool of peripheral blood-derived DNA from 12 normal
females was used as a reference in all experiments. Among the
peripheral blood-derived DNA samples, we identified 2 cases
(of 26; 7.7%) presenting a gain encompassing the Ep CNP locus.
A representative case (AS8) is shown in Fig. 3A. LCL-derived
samples displayed a gain of Ep CNP in 3 cases (of 42; 7.1%) and
deletion of Ep CNP in 3 cases (7.1%). A profile of case N907
presenting a deletion of the locus is illustrated in Fig. 3B.
As outlined above, PCR fragment pools within the SD-22q
locus represent either unique sequences (present in two copies
in a normal diploid genome, Fig. 4A, i) or duplicated sequences
(present in four copies), in cases presenting no gene copy
number variation. The average fluorescence ratio of data points
included in the regional gain encompassing Ep CNP falls into
two categories (Fig. 3A): (a) data points displaying an average
ratio of ∼1.5 (average normalized interlocus fluorescence ratio
(ANILFR) ± 1 standard deviation (1sd), 1.5 ± 0.09), consistent
with the presence of either three copies (vs two copies in the
reference), for pools representing unique segments, or six
versus four copies, for pools representing duplicated sequences,
and (b) data points displaying a ratio of ∼1.25 (ANILFR ± 1sd,
1.27 ± 0.08), consistent with the presence of five (vs four)
copies for pools representing duplicated sequences. The
different comparative ratios are illustrated in Fig. 4B, i–iv.
Two pools on SD-11q (R3 in Fig. 3A) that correspond to
duplicated sequences also display a ratio of ∼1.25
(ANILFR ± 1sd, 1.28 ± 0.08), consistent with the presence of
Fig. 3. Array-CGH profile of three representative cases containing deletions or amplifications affecting SD-22q and/or SD-11q. The y axis represents the normalized
average fluorescence ratio for each data point on the array. On the x axis, five different regions represented on the array are displayed: region 1 (R1) includes 104 pools
of PCR fragments covering a control region on 22q (position in chromosome 22 21,582,907–23,244,260 Mb), centromeric to Ep CNP. Region 2 (R2) contains 65
pools from 22q11 encompassing Ep CNP (see Fig. 1A) (position in chromosome 22 23,755,973–24,494,471 Mb); region 3 (R3) contains 46 pools covering the
chromosome 11 locus, where module V is duplicated, as shown in Fig. 2 (position in chromosome 11 67,708,674–82,451,256 Mb). Region 4 (R4) includes 15 control
pools derived from chromosome X (in blue shading) and region 5 (R5) comprises 35 control pools from autosomes other than chromosome 22. A pool of peripheral
blood-derived DNA from 12 normal females was used as control in all performed experiments. (A) Detection of a regional gain encompassing the Ep CNP locus, in
peripheral blood-derived DNA from a normal male, case AS8. The majority of PCR pools display an average fluorescence ratio of ∼1 (diploid level) (ANILFR ± 1sd,
1.01 ± 0.06), consistent with the presence of two (vs two) gene copies, for unique pools, or four (vs four) gene copies, for pools designed within duplicated regions.
Several PCR pools within the Ep CNP locus display an average fluorescence ratio of ∼1.5 (ANILFR ± 1sd, 1.51 ± 0.09). This is consistent with the presence of three
(vs two) gene copies for unique pools or six (vs four) gene copies for pools designed within segmental duplications. The above two scenarios are represented by blue
spots. Red spots represent PCR pools displaying an intermediate average interlocus fluorescence ratio (∼1.25) (R2 red data points, ANILFR ± 1sd, 1.27 ± 0.08; R3 red
data points, ANILFR ± 1sd, 1.27 ± 0.08), consistent with the presence of five (vs four) gene copies, for pools designed within duplicated regions. The regional gain was
determined to be ∼290 kb in size and chromosome 22 specific. Pools involved in the imbalance were 400_11p–413_01p, positioned at chromosome 22 23,962,961–
24,250,870 (for additional information, see supplementary data). The regional gain was determined to start ∼10 kb downstream of the CRYBB2 gene and to end
∼35 kb upstream of the ADRBK2 gene in this individual. (B) Identification of a deletion affecting the Ep CNP locus in a lymphoblastoid cell line-derived DNA from a
normal male, N907. In this case a few PCR pools within the Ep CNP display a value ANILFR ± 1sd of 0.73 ± 0.06. This is consistent with the presence of one (vs two)
gene copies for unique pools or two (vs four) gene copies for pools designed within duplicated regions. Red spots represent PCR pools displaying an intermediate
average fluorescence ratio (R2 red data points, ANILFR ± 1sd, 0.83 ± 0.05; R3 red data points, ANILFR ± 1sd, 0.89 ± 0.04), consistent with the presence of three (vs
four) gene copies for pools designed within duplicated regions. The size of the deletion is identical to that of the regional gain detected in sample AS8. (C) Detection of
a regional gain encompassing R3 in lymphoblastoid cell line-derived DNA from a neurofibromatosis 2 male patient, case JP. In this case all but two PCR pools within
the Ep CNP display an average fluorescence ratio of∼1.0 (ANILFR ± 1sd, 1.02 ± 0.06), consistent with the presence of two (vs two) or four (vs four) gene copies. Red
spots represent PCR pools displaying an intermediate average fluorescence ratio of ∼1.25 (ANILFR ± 1sd, 1.38 ± 0.04), consistent with the presence of five (vs four)
gene copies, for pools designed within duplicated regions. Average fluorescence ratio for chromosome X pools (R4) is consistent with the presence of one (vs two)
gene copies in all three cases.
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Fig. 4. Graphical illustration of possible comparative ratios for measurement points on the array. Ratios are shown for genomic sequences with no segmental
duplications (i); intrachromosomal duplications in which four copies are very close to each other within the same chromosome (ii); intrachromosomal duplications in
which the duplicated sequences are distant from each other, within the same chromosome (iii); and interchromosomal duplications, in which the duplicated sequences
are located on a chromosome different from the genomic sequence of origin (iv). (A) In situations in which there are no gains or deletions, the average fluorescence
ratio is always ∼1. (B) In the case of gain, a measurement point can present a ratio of ∼1.5 (situations i and ii, data points drawn in blue color in Fig. 3, R2 within Ep
CNP) or an intermediate value of ∼1.25 (situations iii and iv, data points drawn in red color in Fig. 3, R2 within Ep CNP). (C) In the case of deletion, a measurement
point can show a ratio of ∼0.5 (situations i and ii, data points drawn in blue color in Fig. 3, R2 within Ep CNP) or an intermediate value of ∼0.75 (situations iii and iv,
data points drawn in red color in Fig. 3, R2 within Ep CNP).
157C. de Bustos et al. / Genomics 88 (2006) 152–162five (vs four) copies (Fig. 3A). This is explained by the cross-
match of module V sequences within SD-11q to sequences
within the amplified Ep CNP locus in SD-22q. Fig. 3B
illustrates the profile of sample N907 presenting a deletion of
the Ep CNP locus. In this case, “deleted” data points (with an
expected ratio of ∼0.5, observed value ANILFR ± 1sd,
0.73 ± 0.06) can be due to the presence of one (vs two) copies
for unique data points or two (vs four) copies for pools
representing duplicated sequences. On the other hand, data
points included in the regional deletion of the Ep CNP locuswith an expected ratio of ∼0.75 (observed value ANILFR ± 1
sd 0.83 ± 0.05) are consistent with the presence of three (vs
four) copies for pools representing duplicated sequences. These
ratios are exemplified in Fig. 4C, i–iv. Additionally, two pools
on SD-11q (Fig. 3B; R3) representing sequences that are
interchromosomally duplicated in SD-22q also displayed an
expected ratio of∼0.75 (ANILFR ± 1sd, 0.89 ± 0.04), consistent
with the loss of one (of four) copies (Fig. 3B). This is due to the
presence of a deletion within the Ep CNP locus, in SD-22q.
Hybridization experiments shown in Figs. 3A and 3B
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complex SDs, when these are a part of a deletion or gain. The
size of the deletions or gains affecting the Ep CNP locus were
identical in all cases. We display the plots from all experiments
performed in the course of our study on our web site (http://
puffer.genpat.uu.se/publications/supplement/). Ep CNP starts in
a pool of redundant PCR fragments (400_11p; chromosome 22,
23,962,959; see Table S2), located in module I, ∼10 kb
downstream of theCRYBB2 gene (Fig. 1). The last measurement
point that is included in either gain or deletion is also a redundant
pool (413_01; chromosome 22, 24,250,870; see Table S2). It
corresponds to the end of the duplicated module I and is located
∼35 kb upstream of the ADRBK2 gene.
This array was also applied to profile LCL-derived DNA
from a NF2 case (Fig. 3C). This patient had been previously
characterized with a chromosome 22 clone-based array as
containing a 6-Mb heterozygous interstitial deletion of 22q [10]
not covered by the current array. Interestingly, three pools in R2
and two pools in R3 representing duplicated sequences on
module V disclosed a fluorescence ratio of ∼1.25
(ANILFR ± 1sd, 1.38 ± 0.04). This is the only module in SD-
22q that is interchromosomally duplicated within Ep CNP. All
other PCR pools from chromosome 11 disclosed an average
fluorescence ratio of ∼1.5 consistent with gain (three copies vs
two) (Fig. 1B and R3 in Fig. 3C). Therefore, we concluded that
this gain affects specifically chromosome 11. The centromeric
and telomeric borders of this aberration could not be determined
using this array. However, chromosome 11 measurement points
on the array included two additional data points outside the
region of interest, i.e., SD-11q. One of these data points
represents the MEN1 gene (chromosome 11 position
64,327,572–64,335,342) and the second measurement point is
located within the RAB30 gene (chromosome 11 position
82,370,127–82,460,532; see Table S2). Both measurement
points displayed a fluorescence ratio consistent with three gene
copies. Hence, we conclude that the amplification of chromo-
some 11 in the LCL-derived DNA from this patient is at least
18.13 Mb. We also applied a whole human genome scanning
array, with average resolution of approximately 1 Mb [26], to
analyze this LCL sample. These results confirm that this LCL
contains a duplication of the entire chromosome 11 (CGH
profiles shown in supplementary information; http://puffer.
genpat.uu.se/publications/supplement/).
The results pointing out the presence of the deletion/insertion
polymorphism Ep CNP, obtained using the high-resolution
array, were confirmed by the application of an independent
array platform. We used the genomic clone-based chromosome
22 array [10] to profile two samples with copy number gain and
deletion of Ep CNP, which had been characterized using the
high-resolution nonredundant array (Figs. 3A and 3B). Samples
AS8 and N907 displayed gain and deletion, respectively, of the
three clones (AL022332, AL022324, and AL008721) that
encompass the Ep CNP locus (profiles not shown). These
analyses confirmed both gain and deletion of Ep CNP with the
minimal-tiling-path genomic array, as had been described
previously [8,11], and validated the PCR-based high-resolution
approach.In silico analysis of transcripts encoded from the Ep CNP locus
Segmental duplications can produce accurate gene copies or
variants of existing genes, create pseudogenes, or generate
mosaic transcripts derived from segments originated from
different chromosomes [18]. In the currently studied SD-22q
locus, there are two possible transcripts generated by SDs. The
first one, CRYBB2P1, is a result of an intrachromosomal
duplication of a region spanning theCRYBB2 gene, a member of
the crystallin gene family [27,28]. Three of the CRYBB2 exons
(3, 4, and 5) are duplicated 216 kb downstream and form
putative exons (2, 3, and 4) within the pseudogene [29]. The
second putative novel gene in SD-22q was formed as a result of
an interchromosomal duplication. The segment of origin of this
duplication is located in SD-11q and it maps to the well-
characterized LRP5 gene. This gene is a member of the low-
density lipoprotein receptor gene family and is involved in Wnt
signal transduction, via the canonical pathway [30,31]. The
LRP5 gene contains 23 coding exons and a segment of this gene
containing exons 1 through 9 was duplicated to chromosome 22,
followed by several deletion events of the duplicated 22q
segment, which resulted in removal of the duplicated LRP5 exon
2 in SD-22q (details not shown). This putative new chromosome
22 gene produces numerous alternative transcripts. The
strongest evidence for a putative gene, based on the mRNA
expression profile, is the UniGene cluster Hs.272317 (also
known in databases asDKFZp434O0213). The second strongest
cluster of mRNAs is Hs.505497. Both of these transcripts are
capable of encoding proteins that are expressed in various tissues
and make use of different combinations of exons originally
derived from the LRP5 gene. In this context it should be
mentioned that the presence of a gain or a deletion within the Ep
CNP locus does not seem to disrupt any known or predicted
genes. Therefore, this variation should perhaps be viewed from
the perspective of altered dosage of genes located within the
duplicated/deleted segment or in its vicinity.
Almost half of the human genome consists of interspersed
repetitive sequences, which are mainly degraded copies of
transposable elements [32]. Analysis of both SD-22q and SD-
11q revealed slightly higher content of interspersed repeats
than the average content of the human genome (Table S1) [32].
Generation of segmental duplications has been proposed to be
associated with increased content of Alu elements [16,33]. The
content of SINEs in SD-11q was significantly different
(Fisher’s exact test p = 0.031) from the human genome
value (Table S1).
Evolutionary conservation of SD-22q
We also performed a comprehensive evolutionary compar-
ison of sequences among five species. Sequences syntenic to the
human SD-22q segment from Gallus gallus (chicken), Mus
musculus (mouse), Canis familiaris (dog) and Pan troglodytes
(chimpanzee) were aligned and compared against human
sequence using the Multi-PIPmaker (PIP, Percent Identity Plot)
program (http://pipmaker.bx.psu.edu/pipmaker) (Figs. S1 and
S2). Both mouse and dog display conservation of the CRYBB2
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included within the group of nonconserved SDs. Syntenic
chimpanzee sequence is located in chromosome 23 and displays
a very high degree of similarity (average degree of similarity
96%). However, a segment of the chimpanzee sequence with
similarities to human SD-22q is still unmapped. Despite the high
level of conservation, few nonconserved stretches can be found.
The longest is 27.5 kb and is situated upstream of theCRYBB2P1
pseudogene. This pseudogene is highly conserved in chimp
and this can be seen in the chimp–human dot plot (Fig. S1)
or in the full output of the PIP plot (see Fig. S2). Therefore,
we can estimate that these SDs originated at least 4.6 million
years ago, since they are highly conserved in chimp but not
in dog or mouse [34]. Overall, chicken sequence is not well
conserved. However, CRYBB2P1 and CRYBB2 show a
relatively high degree of conservation.
Discussion
Ep CNP is a genomic variation on 22q11 first encountered in
tumor and constitutional DNA from a patient with ependymoma
[8]. Subsequently, a deletion case of Ep CNP was found in one
schwannoma patient and in four patients with pheochromocy-
toma ([11,35] and unpublished results). The fact that a deletion
in the Ep CNP locus has been found in the constitutional DNA of
patients affected with three different types of neuroectodermal
tumors gives rise to the question whether this event represents a
low-penetrance tumor-predisposing genomic alteration or is a
normal polymorphism with no implications for disease devel-
opment. The aim of our study was to develop an array platform
for the detection of gene copy number alterations in unique
sequences, as well as within segmental duplications. We further
applied this array in the analysis of phenotypically normal indi-
viduals with regard to the frequency and extent of Ep CNP. For
this purpose, we created the Sequence Allocator software, which
automates the selection of repeat-free and nonredundant regions
in large chromosomal segments. Nonredundant PCR fragment
pools have been shown to represent reliable measurement points
for array-CGH-based gene copy number analysis [3,22,24]. For
regions with a high content of SDs, where redundancy could not
be avoided, a different approach was taken. PCR fragments were
designed to represent duplicated sequences present in four
copies in the human genome. The use of PCR fragments repre-
senting unique or duplicated sequences as array data points
allowed accurate assessment of the length of the Ep CNP within
the locus containing high sequence complexity, without de-
creasing the resolution of analysis. A few previous studies have
taken into consideration the influence of SDs on array-CGH
ratios of fluorescence. Locke et al. explored the effects of SDs
within array technology by constructing an array covering a
complex region in 15q11–q13 with well-characterized BAC
clones of varying duplication content in addition to unique BAC
clones [20]. A second approach by Wang et al. resulted in a
genomic microarray, constituted by overlapping PACs and
BACs in the same area of interest, 15q11–q14, with a resolution
of 140 kb [21]. The state-of-the-art microarray applied in this
study has improved resolution of analysis considerably (averageresolution of ∼10 kb) and allows characterization of deletions
and gains affecting even a single module in a region containing
segmental duplications.
The analysis of 26 peripheral blood- and 42 LCL-derived
DNA samples from phenotypically normal individuals revealed
that gain of Ep CNP occurs more frequently than deletion of this
locus. The frequency of gains was 7.7 and 7% for peripheral
blood- and LCL-derived DNA, respectively. On the other hand
the frequency of deletions in the same cohort of samples was 0
and 7%, respectively.We cannot fully rule out the possibility that
copy number deletions or gains in LCLs may be a consequence
of rearrangements occurring after immortalization of B cells
[36,37]. However, this interpretation seems unlikely for this
particular locus, given that the percentages of gains and deletions
between peripheral blood- and LCL-derived DNA are similar.
We can hypothesize also that the gain of chromosome 11 in the
LCL-derived DNA from NF2 patient JP might be an aberration
consistent with somatic nondisjunction of this chromosome, as a
consequence of in vitro culturing following the transformation
of the B lymphocytes from this patient with the Epstein–Barr
virus.
Three studies of gene copy number variation among the
normal population have recently shown an unexpectedly high
degree of large-scale polymorphisms [5–7]. By using a 1-Mb-
resolution BAC array, Iafrate et al. identified among 55
unrelated individuals (39 of which were phenotypically
normal), 255 loci affected by copy number variation, which
we refer to here as copy number polymorphisms [5]. Sebat et al.
revealed 76 CNPs among 20 healthy individuals by means of
representational oligonucleotide microarray analysis [6]. Re-
cently, Sharp et al. identified 119 CNPs in 47 normal individuals
using a BAC microarray specifically developed to flank
segmental duplications [7]. In conclusion, of a total of 122
cases analyzed in these three different studies, only two
amplifications (1.6%) and no deletions were found in the Ep
CNP locus. Thus, these and our results point to a higher
frequency of gain of Ep CNP in the general population. The
lower frequency of Ep CNP variation reported in these studies
compared to ours is likely due to technical difficulties
encountered in the analysis of loci containing such a high
amount of redundant sequences. Interestingly, while peripheral
blood-derived DNA from normal controls seems to present a
higher prevalence of Ep CNP gain compared to deletion,
different cohorts of patients affected with neuroectodermal
tumors previously analyzed in our chromosome 22 minimal-
tiling-path array (total of 188 cases) display an inverse
relationship, in which deletion of Ep CNP is a far more
common event (six deletions and no amplifications detected).
Thus, we can hypothesize that gain of Ep CNP occurs more
frequently in normal individuals and might thus be neutral or
play a role in protection against disease. These observations
clearly point to a need for extended genetic and functional
analysis of this variation in a considerably larger number of
patients with tumors and normal controls. This analysis should
preferably be performed in the context of the whole human
genome, as there might be other coexisting forms of large-scale
copy number variation that escaped our detection, because we
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or predicted genes appear to be disrupted by the Ep CNP gain or
deletion. Therefore, an alternative hypothesis is that the altered
gene dosage of Ep CNP might play an important role in the
regulation of genes present in the locus. Alternatively, gain or
loss of Ep CNP could affect genomic stability. Further
possibilities might involve alterations of the chromatin structure
by epigenetic mechanisms due to the presence of copy number
variation. The method followed in this study applied a relatively
small custom-made array for analysis of constitutional DNA,
either blood- or LCL-derived. This approach could be extended
to considerably larger genomic regions, especially improving
the resolution of analysis of regions rich in SDs. These segments
are often difficult to analyze reliably by using genomic clone-
based approaches. Furthermore, an improvement in the current
methodology has already been tested, by showing that
individual PCR fragments also represent reliable gene dosage
measurement points on the arrays [25]. This will further increase
the efficiency of array production and at the same time improve
resolution of arrays. Moreover, our approach could also be
applied to analysis of tumor-derived DNA containing a variety
of gene dosage aberrations. This would naturally require a very
large number of control loci (evenly distributed across the whole
human genome) present on the array for normalization
purposes, to allow the correct assessment of gene copy level.
A common feature of advanced cancer is a complex and highly
aneuploid genome, which requires efficient normalization
procedures. This method is, however, subject to general
limitations of CGH methodology, which are related to the
inability to detect polyploidy and balanced rearrangements [38].
CRYBB2 on chromosome 22 [27,28], and LRP5 on chro-
mosome 11 [30,31] are partially duplicated in the Ep CNP locus.
Mutations in CRYBB2 have been associated with different forms
of cataract [39,40]. On the other hand, LRP5 mutations have
been found in osteoporosis–pseudoglioma syndrome, high bone
mass, and type I diabetes [41–43]. Putative genes from the Ep
CNP locus, such as CRYBB2P1 or DKFZp434O0213, derived
from fusion of duplicated exons from CRYBB2 or LRP5, res-
pectively, as well as new exons, have not yet been linked to any
disease. Interestingly, a mutation of CRYBB2 in family mem-
bers affected with a form of autosomal dominant cataract was
described as a result of a gene conversion event involving
the CRYBB2P1 pseudogene [44]. It is tempting to speculate
that Ep CNP gain or loss might affect the probability of occur-
rence of such an event. Another interesting aspect of the
CRYBB2P1 gene dosage variation might be related to NF2.
These patients frequently display cataracts as part of the disease
phenotype and this feature apparently does not correlate to the
mutational status of the NF2 gene. The Ep CNP region is
located only ∼3.8 Mb from the NF2 locus. Furthermore,
schwannomatosis has been recently defined as a new NF2-
related disease entity and the Ep CNP region is also located
within the segment of 22q segregating with the disease phe-
notype. These disease-related aspects of Ep CNP clearly de-
serve further study.
It should be stressed that Ep CNP has the same size and
identical position of starting and ending points between differentindividuals. Furthermore, the starting and ending points of Ep
CNP match to intrachromosomally duplicated modules (Fig. 1).
This allows us to assume that the copy number variation at the Ep
CNP locus is likely to be a result of NAHR, induced by intra-
chromosomal duplications. It is known that NAHR can give rise
to chromosomal rearrangements such as translocations, dele-
tions, inversions, or duplications. In this context, array-CGH
technology allows us to detect unbalanced translocations, dele-
tions, and gains. However, this methodology reveals neither the
localization nor the orientation of the duplicated segments.
These aspects are of interest when discussing disease predispo-
sition factors, as it has been proposed that individuals who are
heterozygous for an inversion of a given genomic segment might
be at risk of having progeny with a de novo chromosomal re-
arrangement [45].Material and methods
Human material
DNA samples were derived either from peripheral blood (26 normal
individuals of different ethnicities: Caucasians, Asians, and South Americans) or
from lymphoblastoid cell lines (42 LCLs derived from normal individuals in the
UK, European Collection of Cell Cultures, human random collection). Isolation
of DNA from these sources was performed using standard methods [46]. Patient
samples were studied with the approval of the local Research Ethics Committee,
Faculty of Medicine, Uppsala University.
Preparation of the PCR product-based high-resolution array
The array was constructed using a PCR-based repeat-free approach, as
described under Results. An overhang (5′-TGACCATG-3′) was included at the
5′ end of each upper primer. PCR products were amplified in a first round PCR,
utilizing the modified upper primer (with the overhang) and the corresponding
lower primer and conventional PCR protocols. PCR products were subsequently
amplified in a second round PCR using a 5′-amino-modified universal primer
(5′-GCTGAACAGCTATGACCATG-3′) and the corresponding lower primer,
in 60-μl reactions. PCR products were purified using PCR Cleanup Filter Plates,
Montage PCR96 (Millipore, Bedford, MA, USA) and eluted in 50 μl dH2O. Two
to six individual PCR products, containing approximately 2 kb of genomic
sequence, were pooled to a final concentration of 100–200 ng/μl. Fifteen
microliters of spotting buffer (1 M sodium phosphate buffer, pH 8.5, containing
0.001% Sarkosyl) was added to each PCR pool (60 μl) and each pool was
spotted in triplicate on the array using a custom-built printer, with capillary tube
printing pins.
Hybridization, scanning, and image analysis
DNA labeling, hybridization and posthybridization processing, scanning,
and image analysis were performed as previously described [10]. In brief, 2 μg
of test and reference DNAwere differentially labeled by random priming using
Cy3–dCTP (PA53021; GE Healthcare, Piscataway, NJ, USA) and Cy5dCTP
(PA55021; GE Healthcare), respectively. These were then mixed with Cot-1
DNA (Roche, Basel, Switzerland) and hybridized to the array. Twenty-five
micrograms of Cot-1 DNA was used for the PCR-based genomic microarray
hybridizations. Image acquisition was performed using the Axon 4000B
scanner (Axon Instruments, Inc., Union City, CA, USA). Analysis of
hybridization intensity was performed using GenePixPro image analysis
software (Axon Instruments). The average and coefficient of variation of
fluorescence ratios for each measurement point were also calculated. Data
points displaying a coefficient of variation greater than 5% between at least
two of the replica spots were discarded from further analysis. The average of
fluorescence ratios from non-chromosome 22 autosomal controls was used in
161C. de Bustos et al. / Genomics 88 (2006) 152–162the normalization of data in each hybridization experiment. To assess the
average fluorescence values for a given number of measurement points as well
as the interlocus variation, the ANILFR value was calculated as well as the
standard deviation.
Bioinformatic analysis and sequence comparison between species
Sequence Allocator (abbreviated as Allocator) is a bioinformatic program
specially developed to design nonrepetitive and nonredundant PCR fragments.
This program is carefully described under Results and a demo version is available
at our research group web site. To identify sequence segments that have been
conserved during evolution, the orthologous sequences of the human 22q11.2
segment (chromosome 22, 23,920–24,450 kb) were identified in chicken (G.
gallus), mouse (M. musculus), dog (C. familiaris), and chimpanzee (P. trog-
lodytes). Themouse orthologwas identified using the HomologyMap database at
NCBI (mouse chromosome 5, 110,450–110,250 kb). The chimpanzee ortho-
logous sequence, consisting of two contigs (chromosome 23, 24,190–24,540 kb,
and “chrUn_random,” 15,960–16,190 kb), was found by using the UCSC
Genome Browser, utilizing the (“chained”) alignments to the chimpanzee
sequence provided at thisWeb site. Both the “level1” and the “level2” similarities
were used. To identify the dog sequence orthologous to the human segment, the
SyntenyView link of the Ensembl Genome Browser was used (dog chromosome
26, 22,410–22,650 kb). The same link was used to identify the chicken syntenic
region (chicken chromosome 15, 6,940–7,140 kb). Multiple PIP and pair-wise
comparisons human–mouse, human–dog, and human–chimpanzee (dot plots)
were carried out at the PipMaker server using nucleotide sequences that were not
masked for common repeats before submission.Acknowledgments
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